LI
STML

Leap Investments’s Stemline Therapeutics, Inc. STML Stock Holding History

Leap Investments’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-38,700
Closed -$187K – 649
2020
Q1 		$187K Buy
+38,700
New +$251K 0.27% 166

Leap Investments's STML Position: Q2 2020 in Review

Leap Investments sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 38,700 shares — an estimated $187K sold.

Leap Investments first reported a position in STML in Q1 2020 and held it in 1 quarter. The position peaked at $187K in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Leap Investments reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Leap Investments sold 38,700 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $187K.
  • Leap Investments first reported a position in Stemline Therapeutics, Inc. in Q1 2020 and held it in 1 quarter.
  • Leap Investments's Stemline Therapeutics, Inc. position peaked at $187K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.